Clinical Trials in Massachusetts

Showing 14381-14400 of 17,868 trials

Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments

NCT01557192

To demonstrate the efficacy of multiple applications of Low Field Magnetic Stimulation (LFMS) as an antidepressant treatment in subjects with mood disorders.

Bipolar DepressionUnipolar Depression

Mclean Hospital200 participantsStarted May 2010

Belmont, Massachusetts, United States

UNKNOWNPhase 121 miles

A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments

NCT02545192

The investigators propose to make the first observations of LFMS treating a population of subjects with PTSD. A positive outcome for this study could translate directly into a new treatment modality for symptoms of PTSD in both acute and chronic situations. The investigator's goal is to demonstrate the safety and efficacy of LFMS as a possible aid in the treatment of PTSD.

Post Traumatic Stress Disorder

Mclean Hospital24 participantsStarted Sep 2016

Belmont, Massachusetts, United States

COMPLETEDPhase 426 miles

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

NCT00802867

Objectives: * To present the rates of adverse reactions after a dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine. * To present immunogenicity before and after a single dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine.

DiphtheriaTetanusPertussis+2 more

Sanofi Pasteur, a Sanofi Company989 participantsStarted Feb 2004

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • Oakland, California, United States +16 more locations

Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments

A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Find Trials by Condition in Massachusetts

Gluten Sensitivity in Non-Celiac Patients

Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)

Health-related Quality of Life Measure in Pediatric Lupus

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Dose Comparison Study of Menactra® in US Children

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Validity of a New Stroke Dysphagia Screening Tool

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Water-aided Colonoscopy vs Air Insufflation Colonoscopy in Colorectal Cancer Screening